Page 12 — Health Care, Senior & Life Sciences Quarterly — April 2023 www.crej.com DANN BURKE +1 720 528 6362 firstname.lastname@example.org STEPHANI GASKINS +1 720 528 6346 email@example.com ANNA HEISERMAN +1 303 583 2099 firstname.lastname@example.org 500 E HAM PDE N AVE NUE E NG LE WOOD, CO Medical O ce and Retail Space Available ranging from 1,500-20,000 RSF Located On Swedish Medical Center Campus Starbucks and other complementary retail coming soon! WE ARE PLEASED TO WELCOME SHAH AESTHETIC SURGERY BRAND NEW CLASS AA MEDICAL SPACE Dedicated Parking Garage with Valet Built in Referral Source LIFE SCIENCES T he life sciences ecosystem in Colorado has experienced tremendous growth over the past decade, and the momentum will continue to build. The region is on a trajec- tory to crack the top five innovation hubs in the country with competi- tive advantages that favor life sci- ences. What are the keys to building a successful pipeline of life sciences companies in Colorado? Our advan- tages include momentum in the burgeoning cell and gene therapy sector, access to capital, a strong business environment, a highly educated and productive workforce, life sciences leadership, and afford- able real estate opportunities offer- ing room to grow. n Cell and gene therapy momen- tum. Breakthroughs and Food and Drug Administration approvals in cell and gene therapy have given hope to patients. With more than 30 cell and gene therapy companies employing 1,100 in the state – a number that’s expected to double quickly – Colorado has become a cell and gene therapy research mecca. At the heart of this is the Gates Institute at the University of Colorado Anschutz Medical Cam- pus. This $200 million investment expands on the Gates Center for Regenerative Medicine and Gates Biomanufacturing Facility at Fitzsi- mons Innovation Community, two already successful centers for stem cell research and regenerative ther- apies for cancer and other diseases. With two major teaching hospitals, the ecosystem provides biotech- nology companies and manufacturers valuable partner- ships for insti- tutional review boards, regula- tory, early stage manufacturing and clinical trial sup- port. It’s a symbi- otic relationship that allows for quicker-to-market cures for diseases, including those once considered fatal. Space for new cell and gene ther- apy manufacturers like the recently completed Fitzsimons Innovation Community Bioscience 5 build- ing, proximity to academia, and an already thriving life sciences com- munity with top researchers are all elements that contribute to Colo- rado’s momentum. n Access to capital. Our maturing market facilitates investment for biotech companies at all stages of growth. For six years running, the life sciences industry in Colorado has raised over $1 billion. In 2022, early stage companies benefitted from an increase in federal funding and preseed/seed capital, a sign of investor confidence in Colorado’s innovation community. The largest source of funding for Colorado’s life sciences ecosystem came from fed- eral funding that totaled $556 mil- lion, an increase of $125.8 million compared to 2021. Preseed and seed funding increased significantly, with $11.3 million raised, compared to $2.4 million in 2021 (Colorado BioScience Association). Colorado’s health innovation pipe- line begins with seed investments made through the governor’s office, providing matching grants to sup- port a company through the “valley of death” and into regulatory, clini- cal and commercial strategies. The state has awarded more than 450 Advanced Industries Early-Stage Capital and Retention Grants to Col- orado bioscience companies, boast- ing a high success rate and return on investment. Our life sciences community introduces companies to capital through partners like Innosphere Ventures, the Buff Venture Fund and the CU Healthcare Innovation Fund. These funds help bring a spark and sophistication to validat- ing Colorado’s life sciences research and development. n Environment. Altitude is good for innovation. Colorado is a top state for business, technology and entrepreneurship for good reason. Companies that choose Colorado find a business-friendly climate, world-class facilities and research institutions, a central location with global market access, and economic stability. Our economy is strong, ranking as the second-best overall state economy and third-best state for business. The cost of doing busi- ness here is more attractive than hubs on the coasts, with a collabor- ative business culture and favorable tax climate. Our life sciences and business leaders work to protect and grow Colorado’s vibrant life sciences Driving momentum for life sciences in Colorado April Giles Vice president of business development, Fitzsimons Innovation Community Please see Giles, Page 13 Bioscience 5 at Fitzsimons Innovation Community is dedicated to cell and gene manu- facturing, a burgeoning area for the state’s life sciences sector.